Sun Pharma Adv. Res - Quarterly Results
7th May 2019

An increase of about 322.25% to Rs. 848.30 millions in the total revenue was observed for the quarter ended March 2019. The total revenue was pegged at Rs. 200.90 millions during the similar quarter previous year.The Net Loss for the quarter ended March 2019 is Rs. -93.50 millions as compared to Net Profit of Rs. 24.80 millions of corresponding quarter ended March 2018 Operating profit Margin for the quarter ended March 2019 improved to -74.90% as compared to -444.70% of corresponding quarter ended March 2018



(Rs. in Million)


  Quarter ended Year to Date Year ended
  201903 201803 % Var 201903 201803 % Var 201903 201803 % Var
Sales 848.30 200.90 322.25 1828.70 782.60 133.67 1828.70 782.60 133.67
Other Income 44.30 5.20 751.92 135.00 49.40 173.28 135.00 49.40 173.28
PBIDT -74.90 -444.70 -83.16 -1377.80 -2376.80 -42.03 -1377.80 -2376.80 -42.03
Interest 0.40 0.10 300.00 0.90 1.20 -25.00 0.90 1.20 -25.00
PBDT -75.30 45.00 -267.33 -1378.70 -1888.20 -26.98 -1378.70 -1888.20 -26.98
Depreciation 18.20 20.20 -9.90 75.60 81.80 -7.58 75.60 81.80 -7.58
PBT -93.50 24.80 -477.02 -1454.30 -1970.00 -26.18 -1454.30 -1970.00 -26.18
TAX 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Deferred Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT -93.50 24.80 -477.02 -1454.30 -1970.00 -26.18 -1454.30 -1970.00 -26.18
Equity 262.10 250.90 4.46 262.10 250.90 4.46 262.10 250.90 4.46
PBIDTM(%) -8.83 -221.35 -96.01 -75.34 -303.71 -75.19 -75.34 -303.71 -75.19